AI Medica Company Profile

Background

Overview

AI Medica is a healthcare technology company headquartered in Orem, Utah, specializing in automating evidence-based medicine through electronic health record (EHR) data to enhance patient care. Founded in 2019, the company aims to simplify healthcare by delivering the right technology to the right doctor at the right time.

Mission and Vision

AI Medica's mission is to streamline healthcare delivery by providing physicians with timely, data-driven insights, thereby improving patient outcomes and operational efficiency. The company's vision is to be a leader in integrating AI-driven solutions into healthcare systems, fostering a more effective and patient-centric approach to medical practice.

Primary Area of Focus

The company's primary focus is on automating risk calculations and clinical decision support by leveraging EHR data. This approach aims to reduce documentation improvement queries, enhance coding accuracy, and optimize reimbursement processes for healthcare providers.

Industry Significance

In the rapidly evolving healthcare sector, AI Medica stands out by addressing the critical need for efficient data utilization to support clinical decisions. By integrating AI with EHR systems, the company contributes to the broader movement towards value-based care, aiming to improve patient outcomes while controlling costs.

Key Strategic Focus

Core Objectives

• Enhancing Patient Outcomes: Utilizing AI to provide clinicians with actionable insights, leading to more accurate diagnoses and personalized treatment plans.

• Improving Operational Efficiency: Automating routine tasks such as risk calculations and coding to reduce administrative burdens and allow healthcare providers to focus more on patient care.

• Optimizing Reimbursement Processes: Ensuring accurate and efficient coding to maximize reimbursement and minimize documentation improvement queries.

Specific Areas of Specialization

• Clinical Decision Support: Developing AI tools that assist clinicians in making evidence-based decisions by analyzing EHR data.

• Risk Calculation Automation: Automating the calculation of various clinical risk scores to support patient management strategies.

Key Technologies Utilized

• Artificial Intelligence and Machine Learning: Employing advanced algorithms to analyze large datasets and provide predictive insights.

• Electronic Health Record Integration: Seamlessly integrating AI solutions with existing EHR systems to enhance usability and adoption.

Primary Markets or Conditions Targeted

AI Medica primarily targets healthcare providers, including hospitals and clinics, aiming to improve care quality and operational efficiency. The company's solutions are applicable across various medical specialties, focusing on conditions that require complex risk assessments and management strategies.

Financials and Funding

Funding History

As of April 2026, AI Medica has not publicly disclosed detailed information regarding its funding history, total funds raised, or specific investors. The company operates as a privately held entity, and such financial details are not readily available in public records.

Intended Utilization of Capital

While specific details are not disclosed, it is reasonable to infer that any capital raised would be allocated towards:

• Product Development: Enhancing existing AI tools and developing new features to meet evolving healthcare needs.

• Market Expansion: Scaling operations to reach a broader audience within the healthcare sector.

• Research and Development: Investing in R&D to stay at the forefront of AI advancements in healthcare.

Pipeline Development

Key Pipeline Candidates

AI Medica's current focus is on refining its existing AI-driven clinical decision support tools, particularly those that automate risk calculations and coding processes. The company is also exploring the development of new applications that integrate AI with EHR systems to further enhance patient care and operational efficiency.

Stages of Clinical Trials or Product Development

Specific details regarding clinical trials or product development stages are not publicly disclosed. However, the company's emphasis on integrating AI with EHR systems suggests ongoing development and refinement of its technological offerings.

Target Conditions

The company's solutions are designed to assist in the management of various medical conditions that require complex risk assessments, including but not limited to:

• Venous Thromboembolism (VTE): Utilizing age-adjusted D-dimer tests for diagnosis.

• Cardiac Events: Employing risk scores to predict major cardiac events.

• Pulmonary Embolism: Applying the Pulmonary Embolism Severity Index (PESI) for patient stratification.

Relevant Timelines for Anticipated Milestones

While specific timelines are not publicly available, AI Medica is likely working towards:

• Product Enhancements: Ongoing updates to improve the accuracy and usability of its AI tools.

• Regulatory Approvals: Seeking necessary certifications and approvals to expand the deployment of its solutions.

Technological Platform and Innovation

Proprietary Technologies

• Aicode: An AI-driven tool designed to automate coding processes, reducing documentation improvement queries and enhancing reimbursement accuracy.

• Aipro: A platform that integrates AI with EHR systems to provide real-time, evidence-based insights to clinicians.

Significant Scientific Methods

• Evidence-Based Algorithms: Developing algorithms that analyze EHR data to support clinical decision-making.

• Risk Assessment Models: Creating models that calculate various clinical risk scores to aid in patient management.

AI-Driven Capabilities

• Predictive Analytics: Utilizing machine learning to predict patient outcomes and inform treatment plans.

• Natural Language Processing (NLP): Employing NLP to interpret unstructured data within EHRs, enhancing the comprehensiveness of analyses.

Leadership Team

Key Executive Profiles

• Adam M. Robison, MD – Founder & Chief Medical Officer

Dr. Robison founded AI Medica in 2019, bringing a medical background to the company's leadership. His vision is to integrate AI applications seamlessly into clinical workflows to improve patient outcomes and healthcare efficiency.